Log in

Relevant bibliographies by topics / Dermatological Treatment / Journal articles

To see the other types of publications on this topic, follow the link: Dermatological Treatment.

Journal articles on the topic 'Dermatological Treatment'

Author: Grafiati

Published: 5 June 2025

Last updated: 2 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Dermatological Treatment.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Alhomieed, Maya Faissal, Lara Osama Al Hartany, Marya Aref Alghorab, et al. "The Effect of Pregnancy on Dermatological Disorders: A Systematic Review." Clinics and Practice 15, no. 4 (2025): 68. https://doi.org/10.3390/clinpract15040068.

Full text

Abstract:

Background: Pregnancy induces hormonal, immunologic, and vascular changes that profoundly affect dermatologic health. This systematic review aimed to assess the impact of pregnancy on dermatological disorders in terms of disease incidence, severity, maternal-fetal outcomes, and optimal management strategies. Methods: A systematic search was performed in PubMed, MEDLINE, and Web of Science databases, following PRISMA guidelines. Studies evaluating pregnant women with dermatological disorders, pregnancy-related dermatoses, and pre-existing morbidities, were included. The collaboratively extracte

APA, Harvard, Vancouver, ISO, and other styles

2

Tatomirovic, Vesna. "Specifics of dermatological treatment." Sestrinska rec 19, no. 71 (2015): 25–28. http://dx.doi.org/10.5937/sestrec1571025t.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Kochorova, L. V., A. A. Maksimova, and V. S. Skripov. "Experience of dermatological patients’ treatment in the psychosomatic unit." Bulletin of the Russian Military Medical Academy 20, no. 2 (2018): 36–39. http://dx.doi.org/10.17816/brmma12216.

Full text

Abstract:

The patients’ attitude to the possibility of combining the traditional treatment of the basic dermatological disease with psychotherapeutic methods, based on the results of medical and social research, is determined. A social portrait of a dermatological patient of a psychosomatic department has been drawn up, which requires an individual approach in the treatment process. Of all the examined patients, 38,5% of patients had a dermatologic diagnosis, included in the rubric«Dermatitis and eczema». In the structure of psychiatric pathology, the greatest contribution (30,6%) was made by disorders

APA, Harvard, Vancouver, ISO, and other styles

4

Galea, P., and K. M. Goel. "Salicylate poisoning in dermatological treatment." Archives of Disease in Childhood 65, no. 3 (1990): 335. http://dx.doi.org/10.1136/adc.65.3.335.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Rostkowska, Ewelina, Ewa Poleszak, Katarzyna Wojciechowska, and Katarzyna Dos Santos Szewczyk. "Dermatological Management of Aged Skin." Cosmetics 10, no. 2 (2023): 55. http://dx.doi.org/10.3390/cosmetics10020055.

Full text

Abstract:

The subject of the work concerns the dermatological management of patients mainly with aged skin. The purpose of the work was to present the basic techniques and preparations which are performed by dermatologists in the treatment of aged skin. There are dermatological treatments related to the treatment of skin diseases and cosmetic treatments which are mainly related to skin care. In this work, the method of literature research was applied. On the basis of books and journal articles on dermatological and cosmetic procedures for aged skin, an analysis of treatment types was made. Then, the res

APA, Harvard, Vancouver, ISO, and other styles

6

Pendlebury, Gehan A., Peter Oro, William Haynes, Drew Merideth, Samantha Bartling, and Michelle A. Bongiorno. "The Impact of COVID-19 Pandemic on Dermatological Conditions: A Novel, Comprehensive Review." Dermatopathology 9, no. 3 (2022): 212–43. http://dx.doi.org/10.3390/dermatopathology9030027.

Full text

Abstract:

Background: The earliest cases of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China, in December 2019. Since the declaration as a pandemic on 11 March 2020, further dermatological conditions continue to be documented. We herein present a novel literature review of dermatological manifestations associated with the Coronavirus Disease 2019 (COVID-19) pandemic. To date, this literature review is the first broad-spectrum examination that analyzes a range of dermatological manifestations related to the COVID-19 pandemic: infection, vaccinations, personal protectiv

APA, Harvard, Vancouver, ISO, and other styles

7

Polonskaya, A. S., E. A. Shatokhina, A. V. Michenko, and A. Yu Syryseva. "Possibilities of remedial treatment of dermatological adverse events associated with cancer treatment using physical factors." Fizioterapevt (Physiotherapist), no. 3 (June 2, 2023): 89–106. http://dx.doi.org/10.33920/med-14-2303-10.

Full text

Abstract:

Due to the improvement of oncologic services, optimization of surgical treatment methods, and the emergence of new approaches to systemic anti-tumor therapy, a gradual decrease in the mortality rate from malignant tumors has been observed. The changing clinical spectrum of side effects that develop during the treatment of malignant tumors determines the need to optimize approaches to remedial therapy. One of the most common side effects of drug and radiation anti-tumor therapy are dermatological adverse events. The use of physical factors is a promising area in supportive oncology, including w

APA, Harvard, Vancouver, ISO, and other styles

8

Terhaar, Hanna, Mohammad Saleem, and Nabiha Yusuf. "Extracorporeal Photopheresis in Dermatological Diseases." International Journal of Molecular Sciences 25, no. 5 (2024): 3011. http://dx.doi.org/10.3390/ijms25053011.

Full text

Abstract:

Extracorporeal photopheresis (ECP) is an apheresis procedure that is conventionally used as a first-line treatment for cutaneous and leukemic subtypes of T-cell lymphoma, such as Sezary’s syndrome and mycosis fungoides. Over the past three decades, its immunotherapeutic properties have been tested on a variety of autoimmune conditions, including many dermatologic diseases. There is ample evidence of ECP’s ability to modify leukocytes and alter cytokine production for certain dermatologic diseases that have been refractory to first-line treatments, such as atopic dermatitis. However, the eviden

APA, Harvard, Vancouver, ISO, and other styles

9

Almeida, Vera, Daniela Pires, Marta Silva, et al. "Dermatological Side Effects of Cancer Treatment: Psychosocial Implications—A Systematic Review of the Literature." Healthcare 11, no. 19 (2023): 2621. http://dx.doi.org/10.3390/healthcare11192621.

Full text

Abstract:

Cancer is a leading cause of mortality and morbidity all over the world and the second major cause of death in Portugal. Dermatological side effects resulting from cancer treatment have a psychosocial impact on patients’ lives, such as quality of life (QoL), body image, cognitive fusion and social inhibition. This systematic review aimed to explore and synthesize the psychosocial impact of dermatological side effects of cancer treatment, answering the following research objectives: (i) Do the dermatological side effects of the cancer treatment present any psychosocial impact for the patients?

APA, Harvard, Vancouver, ISO, and other styles

10

CHRISTOPHERS, E. "What's new in European dermatological treatment." Journal of the European Academy of Dermatology and Venereology 11 (September 1998): S93. http://dx.doi.org/10.1016/s0926-9959(98)94886-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Rigopoulos, Dimitris, Chrysovalantis Korfitis, Stamatis Gregoriou, and Andreas D. Katsambas. "Infliximab in dermatological treatment: beyond psoriasis." Expert Opinion on Biological Therapy 8, no. 1 (2007): 123–33. http://dx.doi.org/10.1517/14712598.8.1.123.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Kombate, Bignoate, and Kossi Metowogo. "Pharmacological mechanisms of medicinal plant extracts in the treatment of dermatological diseases: in vitro, in vivo studies and clinical trials." Journal of Dermatology & Cosmetology 7, no. 1 (2023): 1–7. http://dx.doi.org/10.15406/jdc.2023.07.00224.

Full text

Abstract:

Dermatological diseases are common inflammatory affections of the skin. In recent times, interest in herbal medicine for the treatment of dermatological diseases has become more than necessary due to the side effects of conventional drugs and their ineffectiveness. To this end, the use of herbal medicine is a promising approach. The objective of this review is to list scientific articles and reviews on plant extracts or plant formulations used in the treatment of dermatological diseases including acne, psoriasis, dermatitis and wounds which are the most common affections. The following scienti

APA, Harvard, Vancouver, ISO, and other styles

13

Pálla, Sára, Kende Lőrincz, András Bánvölgyi, and Márta Medvecz. "Dermatologic aspects of NF1: revised diagnostic criteria and new therapeutic modalities." Bőrgyógyászati és Venerológiai Szemle 98, no. 2 (2022): 88–96. http://dx.doi.org/10.7188/bvsz.2022.98.2.6.

Full text

Abstract:

Neurofibromatosis type 1 is one of the most important autosomal dominant syndromes occurring in the dermatological practice. The authors summarise up-to-date knowledge on neurofibromatosis type 1, focusing on the dermatologic manifestations. In recent years, the diagnostic criteria of the disease were revised based on an international consensus recommendation. Furthermore, a new therapeutic modality has become available for the treatment of inoperable plexiform neurofibroma in children. The authors also summarise the most important dermatologic features of NF1-like syndromes.

APA, Harvard, Vancouver, ISO, and other styles

14

Pandey, Ashish. "Exploring the Intersection of Dentistry and Dermatology: Oral Manifestations in Dermatological Conditions and Implications for Diagnosis and Treatment." Dermatology and Dermatitis 9, no. 7 (2024): 01–02. http://dx.doi.org/10.31579/2578-8949/173.

Full text

Abstract:

Dermatological conditions frequently present with oral symptoms, making the collaboration between dermatology and dentistry crucial. Oral manifestations are often an early sign of systemic dermatological conditions, necessitating the involvement of dentists in both diagnosis and management. This article explores the intersection of dermatology and dentistry, focusing on recent advancements in the treatment of oral lesions associated with dermatological diseases, including dermatitis and autoimmune conditions. A variety of dermatological diseases, such as lichen planus, pemphigus vulgaris, and

APA, Harvard, Vancouver, ISO, and other styles

15

Swanbeck, Gunnar. "Urea in the treatment of dry skin." Acta Dermato-Venereologica 72 (January 1, 1992): 7–8. http://dx.doi.org/10.2340/0001555517778.

Full text

Abstract:

Urea is a unique physiological substance. It has frequently been used in dermatological therapy for more than 20 years. The relevant properties of urea with regard to its use in dermatological preparations are discussed in this brief review. Urea's natural presence in the horny layer, its water solubility, dipolar character and relation to concentrated solutions of electrolytes, are highlighted. The clinical use of urea creams is discussed with respect to indications, side-effects and combinations with other substances.

APA, Harvard, Vancouver, ISO, and other styles

16

O'Reilly, A. M., B. R. Bird, and J. O' Keeffe. "Characteristics of treatment-related dermatological toxicity in colorectal carcinoma." Journal of Clinical Oncology 29, no. 4_suppl (2011): 617. http://dx.doi.org/10.1200/jco.2011.29.4_suppl.617.

Full text

Abstract:

617 Background: The use of novel targeted therapies is becoming increasingly prevalent. This study aimed to determine how novel- targeted therapies have changed the profile of dermatological toxicity in patients being treated for colorectal carcinoma. Methods: Retrospective analysis was performed in a single institution for all patients presenting over a period of 4 weeks. Participants were followed up for the remainder of the study period. Patient charts were reviewed for previou incidences of dermatological toxicity. Toxicity was graded using the Common Toxicity Criteria version 3. Statistic

APA, Harvard, Vancouver, ISO, and other styles

17

DEMİRCİ SAADET, Elif, and Mehmet Emin DEMİR. "Investigation of dermatological manifestations in maintenance hemodialysis patients." Journal of Health Sciences and Medicine 6, no. 6 (2023): 1331–36. http://dx.doi.org/10.32322/jhsm.1352292.

Full text

Abstract:

Aims: Skin findings are common in patients with both chronic kidney disease and undergoing hemodialysis. These findings are observed as nonspecific and specific dermatological manifestations. Our study aimed to describe the characteristics of dermatologic findings of patients with end-stage renal disease undergoing maintenance hemodialysis treatment and to investigate the relationship between these findings and the demographic and clinical features of those patients. Methods: Patients who were admitted to a private hemodialysis clinic in August 2023 were prospectively analyzed. Age, gend

APA, Harvard, Vancouver, ISO, and other styles

18

Kennedy, Roy. "Phototherapy as a Treatment for Dermatological Diseases, Cancer, Aesthetic Dermatologic Conditions and Allergenic Rhinitis in Adult and Paediatric Medicine." Life 13, no. 1 (2023): 196. http://dx.doi.org/10.3390/life13010196.

Full text

Abstract:

The development of light-emitting diodes (LEDs) has led to an increase in the use of lighting regimes within medicine particularly as a treatment for dermatological conditions. New devices have demonstrated significant results for the treatment of medical conditions, including mild-to-moderate acne vulgaris, wound healing, psoriasis, squamous cell carcinoma in situ (Bowen’s disease), basal cell carcinoma, actinic keratosis, and cosmetic applications. The three wavelengths of light that have demonstrated several therapeutic applications are blue (415 nm), red (633 nm), and near-infrared (830 nm

APA, Harvard, Vancouver, ISO, and other styles

19

Kaya, Gökhan, Didem Dizman, and Özlem Su Küçük. "Dermatological manifestations, and drug-induced reactions in COVID-19 patients: an observational study from İstanbul, Turkiye." Journal of Health Sciences and Medicine 7, no. 5 (2024): 555–63. http://dx.doi.org/10.32322/jhsm.1508495.

Full text

Abstract:

Aims: The systemic and respiratory clinical manifestations of coronavirus disease 2019 (COVID-19) include fever, cough, sneezing, sore throat, rhinitis, dyspnoea, chest pain, malaise, fatigue, anorexia, and headache. Moreover, cutaneous manifestations have been observed in 0.2% to 20.4% of cases. This investigation further explores the dermatological manifestations associated with COVID-19 and reactions induced by its pharmacological treatments. Conducted at a university hospital, the study examined 841 patients and identified skin manifestations in 1.5% of cases. It differentiates between sym

APA, Harvard, Vancouver, ISO, and other styles

20

Solanki, Tapan, Sachin Rohani, and Vinayak Joshi. "AYURVEDA APPROACH IN THE MANAGEMENT OF HYPERTROPHIC LICHEN PLANUS – A CASE REPORT." International Ayurvedic Medical Journal 11, no. 11 (2023): 2938–43. http://dx.doi.org/10.46607/iamj4411112023.

Full text

Abstract:

Lichen planus is a dermatological condition with challenging symptoms. Conventional treatments often have limitations. This case report explores the successful Ayurvedic management of hypertrophic lichen planus in a 19- year-old male patient. The treatment involved Purgation (Virechana), oral Ayurvedic medicines, and therapeutic phlebotomy (Raktamokshana). The patient experienced significant relief from symptoms, illustrating the potential of Ayurveda in addressing complex dermatological conditions.

APA, Harvard, Vancouver, ISO, and other styles

21

Goksun Karaman. "Etanercept for the Treatment of Dermatological Diseases." Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 6, no. 3 (2007): 183–87. http://dx.doi.org/10.2174/187152307781368256.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Włodarek, Katarzyna, and Jacek Szepietowski. "The role of vehicles in dermatological treatment." Medycyna Faktów 11, no. 2 (2018): 151–55. http://dx.doi.org/10.24292/01.mf.0218.8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Dutcher, Janice P., Albert Benchabbat, Joan G. Jones, and Peter H. Wiernik. "Unique Dermatological Complication of rhM-CSF Treatment." Leukemia & Lymphoma 15, no. 3-4 (1994): 347–49. http://dx.doi.org/10.3109/10428199409049734.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Patel, Heli, Rishab Revankar, Nikita Revankar, Esther Balogh, Sebastian Kaplan, and Steven Feldman. "44109 Cognitive Behavior Therapy as Dermatological Treatment." Journal of the American Academy of Dermatology 89, no. 3 (2023): AB138. http://dx.doi.org/10.1016/j.jaad.2023.07.552.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Ważniewicz, Sandra, Aleksandra Anioła, and Magdalena Jałowska. "Dermatological procedures in the treatment of hyperhidrosis." Dermatology Review 109, no. 5 (2022): 352–60. http://dx.doi.org/10.5114/dr.2022.125684.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Ladwa, Rahul, Gerald Fogarty, Peggy Chen, et al. "Management of Skin Toxicities in Cancer Treatment: An Australian/New Zealand Perspective." Cancers 16, no. 14 (2024): 2526. http://dx.doi.org/10.3390/cancers16142526.

Full text

Abstract:

Cancer systemic therapeutics and radiotherapy are often associated with dermatological toxicities that may reduce patients’ quality of life and impact their course of cancer treatment. These toxicities cover a wide range of conditions that can be complex to manage with increasing severity. This review provides details on twelve common dermatological toxicities encountered during cancer treatment and offers measures for their prevention and management, particularly in the Australian/New Zealand context where skincare requirements may differ to other regions due to higher cumulative sun damage c

APA, Harvard, Vancouver, ISO, and other styles

27

Franceschin, Ludovica, Alessia Guidotti, Roberto Mazzetto, et al. "Repurposing Historic Drugs for Neutrophil-Mediated Inflammation in Skin Disorders." Biomolecules 14, no. 12 (2024): 1515. http://dx.doi.org/10.3390/biom14121515.

Full text

Abstract:

Neutrophil-mediated inflammation is a key feature of immune-mediated chronic skin disorders, but the mechanistic understanding of neutrophil involvement in these conditions remains incomplete. Dapsone, colchicine, and tetracyclines are established drugs within the dermatologist’s therapeutic armamentarium that are credited with potent anti-neutrophilic effects. Anti-neutrophilic drugs have established themselves as versatile agents in the treatment of a wide range of dermatological conditions. Some of these agents are approved for the management of specific dermatologic conditions, but most of

APA, Harvard, Vancouver, ISO, and other styles

28

Costeris, Charalambos, and Maria Petridou. "The Mediating Role of Appearance Satisfaction and Social Support in the Relationship Between Dermatological Disorders and Patients’ Overall Psychological Distress." Psychology International 7, no. 3 (2025): 62. https://doi.org/10.3390/psycholint7030062.

Full text

Abstract:

Objective: This study aimed to examine whether perceived social support, appearance satisfaction, and self-esteem mediate the relationship between the type of dermatological condition and psychological distress among dermatological patients. Methods: A cross-sectional quantitative study utilizing self-report measures. The sample consisted of 108 dermatological patients aged 18 to 35 years. Participants were divided into two groups based on their diagnosis: Group A included 54 individuals with visible facial cystic acne, and Group B included 54 individuals with non-visible psoriasis or eczema.

APA, Harvard, Vancouver, ISO, and other styles

29

Oliveira, Rita, and Isabel F. Almeida. "Patient-Centric Design of Topical Dermatological Medicines." Pharmaceuticals 16, no. 4 (2023): 617. http://dx.doi.org/10.3390/ph16040617.

Full text

Abstract:

Topical treatments are essential approaches to skin diseases but are associated with poor adherence. Topical vehicles have the primary purpose of ensuring drug effectiveness (by modulating drug stability and delivery, as well as skin properties) but have a marked impact on treatment outcomes as they influence patient satisfaction and, consequently, adherence to topical treatments. There is also a wide variety of vehicles available for topical formulations, which can complicate the decisions of clinicians regarding the most appropriate treatments for specific skin disorders. One of the possible

APA, Harvard, Vancouver, ISO, and other styles

30

Mavrogiorgou, Paraskevi, Corinna Mersmann, Gabriele Gerlach, Stephan Herpertz, and Georg Juckel. "Skin Diseases in Patients with Primary Psychiatric Disorders." Psychiatry Investigation 17, no. 2 (2020): 157–62. http://dx.doi.org/10.30773/pi.2019.0193.

Full text

Abstract:

Objective The few psychodermatological studies of primary psychiatric populations so far suggest that parasitic-infectious skin diseases are the most common dermatological comorbidity in more than 70% of psychiatric patients, which should be studied here in a large data bank outside dermatological treatment facilities.Methods In a descriptive-explorative and retrospective study, more than 17,000 patients with primary psychiatric disorders were examined to investigate dermatological comorbidities.Results The proportion of patients with primary mental disorders and additional dermatological dise

APA, Harvard, Vancouver, ISO, and other styles

31

Khvorik, Dimitrij. "History of syphilis and dermatologic and venereal care in Grodno." Medical Science Pulse 14, SUPPLEMENT 1 (2013): 1–7. http://dx.doi.org/10.5604/01.3001.0014.6949.

Full text

Abstract:

The article provides historical data on the development of dermatological-venereal aid in Grodno region over the last centuries. the authors describe the history, epidemiology and risk factors of syphilis in Grodno. the data present the history of treatment and prevention of sexually transmitted infections from the beginnings of the 18th century until the end of the 20th century. the information has been collected on the basis of medical documents stored by the Grodno national archives. the article comprises unique facts of the treatment provided for the infected in various historical periods.

APA, Harvard, Vancouver, ISO, and other styles

32

Kochhar, Suneeta. "Treatment and management of acne in primary care settings." Independent Nurse 2021, no. 6 (2021): 18–19. http://dx.doi.org/10.12968/indn.2021.6.18.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Shatokhina, E. A., A. G. Turkina, and L. S. Kruglova. "Dermatologic adverse events of Bcr-Abl tyrosine kinase inhibitors." Russian journal of hematology and transfusiology 65, no. 2 (2020): 154–73. http://dx.doi.org/10.35754/0234-5730-2020-65-2-154-173.

Full text

Abstract:

Introduction. The majority of drugs used for targeted antitumor therapy are associated with dermatological toxicities. Dermatological adverse events significantly affect patient quality of life and can require the modification of treatment regimens with Bcr-Abl tyrosine kinase inhibitors.Aim. to analyze specific skin adverse events of Bcr-Abl tyrosine kinase inhibitors in accordance with their activity against the main and additional protein kinase targets.Main Findings. This article presents data on dermatological adverse events, possible mechanisms for their development, as well as a clinica

APA, Harvard, Vancouver, ISO, and other styles

34

Balasubramaniam, Darshana, and Craig G. Burkhart. "Hydrogen Peroxide Use for Chemical Destruction in Seborrheic Keratosis: A Review." Open Dermatology Journal 13, no. 1 (2019): 68–70. http://dx.doi.org/10.2174/1874372201913010068.

Full text

Abstract:

Seborrheic Keratosis (SK) is a common, benign epidermal tumor as observed by dermatologists. Removal is rarely indicated, and usually requested by patients for cosmetic preference. The most common method of removal is cryotherapy, but other topical treatments exist. Topical Hydrogen Peroxide has been recognized as an effective topical treatment. Safety concerns and maximum efficiency of peroxides have been a topic of study in a variety of dermatological conditions. This article aims to review the chemical composition of hydrogen peroxide (H202) in treating SK, methods to increase its effective

APA, Harvard, Vancouver, ISO, and other styles

35

Patil, Ragini. "Ayurveda for Dermatological Solutions." PDEAS International Journal of Research in Ayurved and Allied Sciences 3, no. 2 (2019): 1–2. https://doi.org/10.63778/pdeasijraas-arjcpl/2019_10311.

Full text

Abstract:

Skin diseases, ranging from common conditions like acne and eczema to chronic ailments such as psoriasis and vitiligo, continue to challenge dermatological care worldwide. Ayurveda, with its deep-rooted knowledge of skin (Twacha) health and holistic treatment principles, offers promising integrative approaches for managing a wide spectrum of dermatological disorders. This editorial highlights the scope, relevance, and emerging evidence of Ayurvedic solutions in dermatology, while emphasizing the need for rigorous scientific validation.

APA, Harvard, Vancouver, ISO, and other styles

36

Bambauer, Rolf. "Therapeutic Apheresis, Immunosuppression, and Human Monoclonal Antibodies in Dermatologic Diseases." Advance Research in Dermatology & Cosmetics (ARDC) 3, no. 1 (2024): 1–9. http://dx.doi.org/10.54026/ardc/1017.

Full text

Abstract:

Severe and/or refractory dermatological diseases with immunologic origin to conventional therapy have a bad prognosis. Autoimmune blistering diseases have a high morbidity and mortality. Therapeutic apheresis is an essential supportive treatment for severe and refractory dermatological diseases with an immunologic origin, particularly autoimmune blistering diseases. This approach has been shown to significantly improve the prognosis of these diseases. Therapeutic apheresis, combined with immunosuppressive therapy and/or human monoclonal antibodies, has treated successfully autoimmune blisterin

APA, Harvard, Vancouver, ISO, and other styles

37

Juhász, István, Éva Szabó, Irén Erdei, Lenke Jenei Kluch, Hanna Kiss, and Zoltán Péter. "Forty years of the burn service at the Department of Dermatology in Debrecen." Bőrgyógyászati és Venerológiai Szemle 99, no. 4 (2023): 287–92. http://dx.doi.org/10.7188/bvsz.2023.99.4.6.

Full text

Abstract:

For decades the burn patients have been treated at dermatological institutions worldwide, due to the similarities of the burns to certain blistering dermatological conditions. Another explanation was the routine of these clinics in the conservative treatment of wounds and general care of patients with extensive skin defects. Later on, together with more knowledge about the pathomechanism of burns and as the operative treatment became dominant, complex burn care was provided by specialized burn departments. Thanks to these developments, most burn care institutions nowadays are either autonomous

APA, Harvard, Vancouver, ISO, and other styles

38

Costeris, Charalambos, Maria Petridou, and Yianna Ioannou. "Social Support and Appearance Satisfaction Can Predict Changes in the Psychopathology Levels of Patients with Acne, Psoriasis and Eczema, before Dermatological Treatment and in a Six-Month Follow-up Phase." Psych 3, no. 3 (2021): 259–68. http://dx.doi.org/10.3390/psych3030020.

Full text

Abstract:

This was a cross-sectional study which assessed the factors that predicted changes in the levels of psychopathological symptomatology of patients with acne, psoriasis and eczema both before dermatological treatment and in a six-month follow-up phase. One hundred and eight dermatological patients (18–35 years) participated in the study; 54 with visible facial cystic acne (Group A), and 54 with non-visible psoriasis/eczema (Group B). A battery of self-report questionnaires were administered to all patients before their dermatological treatment and in a six-month follow-up phase and included: the

APA, Harvard, Vancouver, ISO, and other styles

39

Guenther, Lyn, Charles Lynde, and Yves Poulin. "Off-Label Use of Topical Calcineurin Inhibitors in Dermatologic Disorders." Journal of Cutaneous Medicine and Surgery 23, no. 4_suppl (2019): 27S—34S. http://dx.doi.org/10.1177/1203475419857668.

Full text

Abstract:

Off-label prescribing is a common practice in dermatology, particularly when uncommon dermatologic diseases have limited or no approved treatment options. Topical calcineurin inhibitors are approved for the treatment of eczema, and their anti-inflammatory, immunomodulatory, and steroid-sparing effects make them an attractive therapeutic option for a wide variety of other dermatologic diseases. This review summarizes and qualifies the available evidence supporting the clinical effectiveness of tacrolimus ointment and pimecrolimus cream in non-eczema indications. There is high-quality evidence s

APA, Harvard, Vancouver, ISO, and other styles

40

Sheppard, N. P., S. O'Loughlin, and J. P. Malone. "Psychogenic Skin Disease: A Review of35Cases." British Journal of Psychiatry 149, no. 5 (1986): 636–43. http://dx.doi.org/10.1192/bjp.149.5.636.

Full text

Abstract:

In three years of clinical practice, the authors saw 35 cases of dermatological disorders of strictly psychological origin-8 patients withdermatitis artefacta, 8 with delusional parasitosis, and 19 who presented with skin complaints but showed no dermatological pathology (‘dermatological non-disease’). All but two initially presented for dermatological opinion rather than psychiatric assessment, and 12 refused psychiatric referral. Demographic and clinical details of all 35 cases are given, including possible related factors, course, treatment, and outcome, and the cases are discussed in the c

APA, Harvard, Vancouver, ISO, and other styles

41

Khanna, Raveena, Emily Boozalis, Micah Belzberg, John G. Zampella, and Shawn G. Kwatra. "Mirtazapine for the Treatment of Chronic Pruritus." Medicines 6, no. 3 (2019): 73. http://dx.doi.org/10.3390/medicines6030073.

Full text

Abstract:

Background: Chronic pruritus is a debilitating condition associated with a wide range of dermatologic, systemic and psychogenic etiologies. In patients with chronic pruritus that is refractory to conventional therapy, symptoms can significantly decrease quality of life by contributing to anxiety, sleep disturbances, and in many cases depression. Recent studies have demonstrated the effectiveness of mirtazapine in relieving chronic itch that is refractory to standard first-line therapies. Methods: We searched PubMed for English-language articles containing the words (“pruritus” or “itch”) AND “

APA, Harvard, Vancouver, ISO, and other styles

42

Okhlopkov, V. A., E. A. Lyalyukova, E. N. Chernysheva, E. V. Nadey, G. M. Konovalova, and A. V. Lyalyukov. "Diet, dermatological diseases and comorbidity: aspects of prevention and treatment." Experimental and Clinical Gastroenterology 183, no. 11 (2020): 140–46. http://dx.doi.org/10.31146/1682-8658-ecg-183-11-140-146.

Full text

Abstract:

The purpose of the review was to study the data of the modern literature on the eﬀect of diet on the skin condition and the course of some dermatological diseases. Recent studies have shown a strong link between diet and a number of dermatological conditions. Food allergies and Western eating patterns can dramatically alter microbiome composition and intestinal permeability. In conditions of disturbed microbial balance and changes in the barrier function of the intestine, the penetration of immunogenic molecules into the systemic circulation, including food antigens, bacterial toxins and patho

APA, Harvard, Vancouver, ISO, and other styles

43

Kim, Suyeon, Yu Ri Woo, Sang Hyun Cho, Jeong Deuk Lee, and Hei Sung Kim. "Clinical Efficacy of 5-Fluorouracil and Bleomycin in Dermatology." Journal of Clinical Medicine 13, no. 2 (2024): 335. http://dx.doi.org/10.3390/jcm13020335.

Full text

Abstract:

Bleomycin and 5-fluorouracil (5-FU) are widely used in various dermatological disorders. Both drugs are well-recognized as antineoplastic drugs and exert their effect by blocking the cell cycle. Topical and intralesional formulations are available and have been studied in both non-neoplastic and cancerous lesions. However, data comparing the effect of bleomycin and 5-FU in the dermatological disorders are limited. This review outlines the action mechanisms of both drugs and compares their clinical efficacies in a wide range of dermatologic diseases including hypertrophic scar, wart, skin cance

APA, Harvard, Vancouver, ISO, and other styles

44

Yamamoto, T. "The Dermatological Examination and Treatment on the Aged." Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 33, no. 6 (1996): 424–29. http://dx.doi.org/10.3143/geriatrics.33.424.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Satoh, Yoshiaki. "Artificial Light Sources for Dermatological Diagnosis and Treatment." JOURNAL OF THE ILLUMINATING ENGINEERING INSTITUTE OF JAPAN 72, no. 12 (1988): 725–29. http://dx.doi.org/10.2150/jieij1980.72.12_725.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Serup, J., ?K Lindblad, M. Maroti, et al. "To Follow or Not to Follow Dermatological Treatment." Acta Dermato-Venereologica 86, no. 3 (2006): 193–97. http://dx.doi.org/10.2340/00015555-0073.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Woźniak, Katarzyna, Marian Dmochowski, Waldemar Placek, et al. "Pemphigoid – diagnosis and treatment. Polish Dermatological Society Consensus." Dermatology Review 1 (2016): 19–34. http://dx.doi.org/10.5114/dr.2016.57738.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Thacher, Scott M., Jayasree Vasudevan, Kwok-Yin Tsang, Sunil Nagpal, and Roshantha A. S. Chandraratna. "New Dermatological Agents for the Treatment of Psoriasis." Journal of Medicinal Chemistry 44, no. 3 (2001): 281–97. http://dx.doi.org/10.1021/jm0000214.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Grunewald, Sonja, Uwe Paasch, and Hans-Jürgen Glander. "Systemic dermatological treatment with relevance for male fertility." JDDG 5, no. 1 (2007): 15–21. http://dx.doi.org/10.1111/j.1610-0387.2007.06169.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Lomholt, Gunnar. "Conditions for Dermatological Treatment in a Developing Country." International Journal of Dermatology 29, no. 7 (1990): 511–14. http://dx.doi.org/10.1111/j.1365-4362.1990.tb04847.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!